These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 11230491)
1. Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data. Du X; Goodwin JS J Clin Oncol; 2001 Mar; 19(5):1455-61. PubMed ID: 11230491 [TBL] [Abstract][Full Text] [Related]
2. CMF-regimen preferred as first-course chemotherapy for older and sicker women with breast cancer: Findings from a SEER-Medicare-based population study. Kadakia A; Rajan SS; Abughosh S; Du XL; Johnson ML Am J Clin Oncol; 2015 Apr; 38(2):165-73. PubMed ID: 23608830 [TBL] [Abstract][Full Text] [Related]
3. Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000. Harlan LC; Clegg LX; Abrams J; Stevens JL; Ballard-Barbash R J Clin Oncol; 2006 Feb; 24(6):872-7. PubMed ID: 16484696 [TBL] [Abstract][Full Text] [Related]
4. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States. Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670 [TBL] [Abstract][Full Text] [Related]
5. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999. Mariotto AB; Feuer EJ; Harlan LC; Abrams J J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888 [TBL] [Abstract][Full Text] [Related]
6. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database. Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406 [TBL] [Abstract][Full Text] [Related]
7. Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants. Lamont EB; Herndon JE; Weeks JC; Henderson IC; Lilenbaum R; Schilsky RL; Christakis NA J Natl Cancer Inst; 2005 Jul; 97(14):1080-3. PubMed ID: 16030306 [TBL] [Abstract][Full Text] [Related]
8. Temporal and geographic variation in the use of hematopoietic growth factors in older women receiving breast cancer chemotherapy: findings from a large population-based cohort. Du XL; Lairson DR; Begley CE; Fang S J Clin Oncol; 2005 Dec; 23(34):8620-8. PubMed ID: 16314624 [TBL] [Abstract][Full Text] [Related]
9. Risk of dementia in older breast cancer survivors: a population-based cohort study of the association with adjuvant chemotherapy. Baxter NN; Durham SB; Phillips KA; Habermann EB; Virning BA J Am Geriatr Soc; 2009 Mar; 57(3):403-11. PubMed ID: 19278395 [TBL] [Abstract][Full Text] [Related]
10. Risk of incident claims for chemotherapy-induced peripheral neuropathy among women with breast cancer in a Medicare population. Greenwald MK; Ruterbusch JJ; Beebe-Dimmer JL; Simon MS; Albrecht TL; Schwartz AG Cancer; 2019 Jan; 125(2):269-277. PubMed ID: 30387871 [TBL] [Abstract][Full Text] [Related]
11. Clinical and economic outcomes associated with adjuvant chemotherapy in elderly patients with early stage operable breast cancer. Sail KR; Franzini L; Lairson DR; Du XL Value Health; 2012 Jan; 15(1):72-80. PubMed ID: 22264974 [TBL] [Abstract][Full Text] [Related]
12. An algorithm for the use of Medicare claims data to identify women with incident breast cancer. Nattinger AB; Laud PW; Bajorunaite R; Sparapani RA; Freeman JL Health Serv Res; 2004 Dec; 39(6 Pt 1):1733-49. PubMed ID: 15533184 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of three algorithms to identify incident breast cancer in Medicare claims data. Gold HT; Do HT Health Serv Res; 2007 Oct; 42(5):2056-69. PubMed ID: 17850533 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort. Elkin EB; Hurria A; Mitra N; Schrag D; Panageas KS J Clin Oncol; 2006 Jun; 24(18):2757-64. PubMed ID: 16782916 [TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness of Chemotherapy for Breast Cancer and Age Effect in Older Women. Lairson DR; Parikh RC; Cormier JN; Chan W; Du XL Value Health; 2015 Dec; 18(8):1070-8. PubMed ID: 26686793 [TBL] [Abstract][Full Text] [Related]
16. Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment. Cooper GS; Yuan Z; Stange KC; Dennis LK; Amini SB; Rimm AA Med Care; 2000 Apr; 38(4):411-21. PubMed ID: 10752973 [TBL] [Abstract][Full Text] [Related]
17. Association between adjuvant chemotherapy and risk of acute kidney injury in elderly women diagnosed with early-stage breast cancer. Li S; Liu J; Virnig BA; Collins AJ Breast Cancer Res Treat; 2017 Feb; 161(3):515-524. PubMed ID: 27933451 [TBL] [Abstract][Full Text] [Related]
18. Effects of Previous Medication Regimen Factors and Bipolar and Psychotic Disorders on Breast Cancer Endocrine Therapy Adherence. Haskins CB; Neuner JM; McDowell BD; Carnahan RM; Fiedorowicz JG; Wallace RB; Smith BJ; Chrischilles EA Clin Breast Cancer; 2020 Jun; 20(3):e261-e280. PubMed ID: 32139273 [TBL] [Abstract][Full Text] [Related]
19. Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer. Du X; Freeman JL; Warren JL; Nattinger AB; Zhang D; Goodwin JS Med Care; 2000 Jul; 38(7):719-27. PubMed ID: 10901355 [TBL] [Abstract][Full Text] [Related]
20. Treatment for breast cancer in patients with Alzheimer's disease. Gorin SS; Heck JE; Albert S; Hershman D J Am Geriatr Soc; 2005 Nov; 53(11):1897-904. PubMed ID: 16274370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]